91
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Risankizumab for the Treatment of the Patients with Moderate to Severe Plaque Psoriasis During a 24-Week Period: Real-Life Experience

ORCID Icon, &
Pages 3653-3659 | Received 19 Oct 2023, Accepted 13 Dec 2023, Published online: 19 Dec 2023